The Sanofi S1P1 agonist, SAR247799 , is a biased agonist of the S1P1 sphingosine receptor, preferentially activating G-protein signaling over the β-arrestin and internalization pathways. Commercial S1P1 modulators such as fingolimod and ozanimod exert their immunosuppressive effects in multiple sclerosis and other diseases primarily by [...]
< 1 minute read
Nov. 26, 2021
SAR247799: A Biased Agonist of the S1P1 Sphingosine Receptor
SAR247799
G-protein biased GPCR agonist oral 10 mg QD, phase I, cardiovascular from HTS and opt. bioRxiv Sanofi